The informative value of proadrenomedullin in patients with severe COVID-19

The informative value of proadrenomedullin in patients with severe COVID-19

Subjects and methods. The retrospective study included 37 patients (n = 37) diagnosed with severe viral pneumonia (SARS-CoV2) who were treated in the intensive care unit of Pavlov First Saint Petersburg State Medical University. To assess the significance of PADM as a biomarker of bacterial infectio...

Full description

Bibliographic Details
Main Authors:	D. A. Malinina, I. V. Shlyk, Yu. S. Polushin, A. A. Аfanasiev, O. V. Stanevich, E. A. Bakin
Format:	Article
Language:	Russian
Published:	NEW TERRA Publishing House 2020-12-01
Series:	Вестник анестезиологии и реаниматологии
Subjects:	proadrenomedullin covid-19 sepsis prediction of outcome
Online Access:	https://www.vair-journal.com/jour/article/view/478

Similar Items

Diagnostic and prognostic value of proadrenomedullin in neonatal sepsis
by: Sameh Samir Fahmey, et al.
Published: (2018-05-01)

Proadrenomedullin determining clinical severity and analyzing prognostic value for pneumonia
by: Sedat Demirsoy, et al.
Published: (2019-01-01)

Proadrenomedullin in Sepsis and Septic Shock: A Role in the Emergency Department
by: Andrea Piccioni, et al.
Published: (2021-09-01)

The clinical significance of proadrenomedulin level in blood in sepsis patients
by: V. A. Rudnov, et al.
Published: (2019-11-01)

A study of mid-regional-proadrenomedullin in community-acquired pneumonia and sepsis as a prognostic marker
by: Radwa Morsy, et al.
Published: (2019-01-01)

Mid-Regional Proadrenomedullin as a New Biomarker of Kidney and Cardiovascular Diseases—Is It the Future?
by: Katarzyna Czajkowska, et al.
Published: (2021-02-01)

Relationship of plasma proadrenomedullin and cortisol levels with systemic inflammatory response and target organ damage in children with sepsis after burn
by: Xing Wei, et al.
Published: (2017-08-01)

MR-Proadrenomedullin as biomarker of renal damage in urinary tract infection in children
by: Rafael Peñalver Penedo, et al.
Published: (2021-06-01)

Effectiveness of Proadrenomedullin Enhanced CURB65 Score Algorithm in Patients with Community-Acquired Pneumonia in “Real Life”, an Observational Quality Control Survey
by: Daniel Widmer, et al.
Published: (2014-03-01)

The effect of adrenomedullin and proadrenomedullin N- terminal 20 peptide on angiotensin II induced vascular smooth muscle cell proliferation
by: Jian Ma, et al.
Published: (2016-01-01)

The Integration of qSOFA with Clinical Variables and Serum Biomarkers Improves the Prognostic Value of qSOFA Alone in Patients with Suspected or Confirmed Sepsis at ED Admission
by: Filippo Mearelli, et al.
Published: (2020-04-01)

Circulating MR-proADM levels, as an indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients
by: Luis García de Guadiana-Romualdo, et al.
Published: (2021-10-01)

Biomarkers of infection in the optimization of antibacterial therapy: justified expectations
by: Kulabukhov V.V., et al.
Published: (2020-10-01)

Sepsis, Phages, and COVID-19
by: Andrzej Górski, et al.
Published: (2020-10-01)

Severe COVID-19 and Sepsis: Immune Pathogenesis and Laboratory Markers
by: Mai M. Zafer, et al.
Published: (2021-01-01)

Evaluation of microcirculation disorders in patients with severe COVID-19 by nail bed capillaroscopy
by: Е. Е. Ladozhskaya-Gapeenko, et al.
Published: (2021-03-01)

Immune-Response Patterns and Next Generation Sequencing Diagnostics for the Detection of Mycoses in Patients with Septic Shock—Results of a Combined Clinical and Experimental Investigation
by: Sebastian O. Decker, et al.
Published: (2017-08-01)

Immunodepression COVID-19-related as a promoting factor for severe Pseudomonas sepsis in an infant with not respiratory symptoms
by: Letizia Zenzeri, et al.
Published: (2021-01-01)

Clinical outcomes of using remdesivir in patients with moderate to severe COVID-19: A prospective randomised study
by: Lakshmi Mahajan, et al.
Published: (2021-01-01)

Parallels in Sepsis and COVID-19 Conditions: Implications for Managing Severe COVID-19
by: Charles Ochieng’ Olwal, et al.
Published: (2021-02-01)

Validation of the REGARDS Severe Sepsis Risk Score
by: Henry E. Wang, et al.
Published: (2018-12-01)

Surviving and thriving in thrombosis research during a global pandemic: Experiences of a vascular scientist diagnosed with COVID-19
by: Addie B. Spier, et al.
Published: (2021-01-01)

The prognostic value of serial troponin measurements in patients admitted for COVID‐19
by: Vincenzo Nuzzi, et al.
Published: (2021-10-01)

Unique case of central retinal artery occlusion secondary to COVID-19 disease
by: Sudeep Acharya, et al.
Published: (2020-01-01)

Comparison of renal histopathology and gene expression profiles between severe COVID-19 and bacterial sepsis in critically ill patients
by: Meint Volbeda, et al.
Published: (2021-06-01)

COVID-19 biobank: features of the cytokine profile
by: N. N. Sushentseva, et al.
Published: (2020-12-01)

A Nomogram-Based Prediction for Severe Pneumonia in Patients with Coronavirus Disease 2019 (COVID-19)
by: Zhang Y, et al.
Published: (2020-10-01)

COVID-19 Associated Coagulopathy and Implications for its Treatment
by: Cherneva Zh., et al.
Published: (2020-09-01)

Prognostic value of NT-proBNP in patients with severe COVID-19
by: Lei Gao, et al.
Published: (2020-04-01)

Comparison of the coagulopathies associated with COVID‐19 and sepsis
by: Robert A. Campbell, et al.
Published: (2021-05-01)

Endotoxemia and circulating bacteriome in severe COVID-19 patients
by: Phatadon Sirivongrangson, et al.
Published: (2020-12-01)

Extracorporeal membrane oxygenation in the complex therapy for septic shock in a patient with severe lung damage caused by COVID-19
by: E. A. Popov, et al.
Published: (2021-06-01)

COVID-19 in pregnancy: A review
by: Shikhar Tripathi, et al.
Published: (2020-01-01)

Predictive factors of progression to severe COVID-19
by: Zhou Yi-Hong, et al.
Published: (2020-08-01)

Development and Validation of a Predictive Model for Severe COVID-19: A Case-Control Study in China
by: Zirui Meng, et al.
Published: (2021-05-01)

The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy
by: Hong-Yuan Lin
Published: (2020-08-01)

Hypoalbuminemia as a predicator of mortality of sepsis from COVID-19. Hospital II Chocope, 2020.
by: Alex Brandon Lopez, et al.
Published: (2021-01-01)

Resolution of Disseminated Intravascular Coagulation in a Patient with COVID-19 and Associated Sepsis—Induced Neutropenia
by: Pierpaolo Di Micco, et al.
Published: (2021-01-01)

Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis
by: Jorge Gabriel Ruiz-Sánchez, et al.
Published: (2020-11-01)

Risk Factors for Development and Severity of COVID-19 in COPD Patients
by: Matteo Bonato, et al.
Published: (2021-08-01)

Cannot write session to /tmp/vufind_sessions/sess_5i7mq39t9q2v59rigc6lr2aml6